Svb Wealth LLC Amarin Corp Plcuk Transaction History

Svb Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.82 - $1.35 $16,400 - $27,000	-20,000 Reduced 33.33%	40,000 $35,000
Q4 2023 Jan 30, 2024	BUY	$0.66 - $0.91 $19,800 - $27,300	30,000 Added 100.0%	60,000 $52,000
Q3 2023 Oct 23, 2023	SELL	$0.85 - $1.43 $5,950 - $10,010	-7,000 Reduced 18.92%	30,000 $27,000
Q4 2022 Feb 10, 2023	BUY	$1.07 - $1.34 $28,890 - $36,180	27,000 Added 270.0%	37,000 $44,000
Q3 2022 Nov 09, 2022	BUY	$1.09 - $1.67 $10,900 - $16,700	10,000 New	10,000 $11,000
Q1 2020 May 11, 2020	SELL	$4.0 - $21.53 $38,000 - $204,535	-9,500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $132,430 - $229,140	9,500 New	9,500 $204,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Svb Wealth LLC with notifications on news.